Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-09-29 to 2022-10-21
Current total value of award: $51095.52
Description: 4558650803!TYSABRI 300 MG/15 ML VIAL 15ML